Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis

Narci Teoh1, Pawan Pyakurel, Yock Young Dan

  • 1Australian National University Medical School at The Canberra Hospital, Canberra, Australia.

Gastroenterology
|November 19, 2009
PubMed
Abstract

Insights

Mice lacking ATM kinase are protected from liver cancer induced by diethylnitrosamine (DEN). This refractoriness is linked to increased p53 and apoptosis, preventing malignant transformation in hepatocytes.

Area of Science:

  • Hepatology
  • Cancer Biology
  • DNA Damage Response

Background:

  • p53 mutations are frequent in human hepatocellular carcinoma (HCC).
  • Ataxia Telangiectasia Mutated (ATM) kinase detects DNA breaks and activates p53.
  • The role of ATM in DEN-induced hepatocarcinogenesis is unknown.

Purpose of the Study:

  • To investigate if ATM deficiency impacts DEN-induced liver cancer.
  • To assess the effect of ATM deficiency on p53 activation and hepatocyte response to DEN.

Main Methods:

  • Mice with varying ATM gene status (ATM(-/-), ATM(+/-), WT) were injected with DEN.
  • Liver tissues were analyzed for p53, cell cycle markers, apoptosis, and tumor development up to 12 months.

Main Results:

  • ATM-deficient mice showed no HCC development after DEN exposure, unlike WT and heterozygote mice.
  • ATM(-/-) livers exhibited elevated p53, p19ARF, ATR, Chk1, and apoptosis markers.
  • Senescence markers were present, alongside telomerase upregulation, suggesting potential immortalization of DEN-treated ATM(-/-) hepatocytes.

Conclusions:

  • ATM deficiency abrogates DEN-induced hepatocarcinogenesis.
  • ATR/Chk1/p53 pathway activation and subsequent apoptosis/cell cycle arrest protect ATM(-/-) hepatocytes from malignant transformation.
  • Sustained p53 induction with senescence features does not necessarily lead to organ failure.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...